Research Article
Calcium Phosphorus Nanoparticles Coloaded with Paclitaxel and ADAM-10-siRNA for the Treatment of Triple Negative Breast Cancer
Figure 5
Biological safety of calcium phosphorus nanodrug delivery system. Three days after the last injection, blood was collected for biochemical analysis. (a–d) Plasma levels of AST (a), ALT (b), CREA (c), and UREA (d) analysis. (e) H&E staining of organs after the last treatment to evaluate side effects. Scale bar, 50 μm. Data as (, , ).
(a) |
(b) |
(c) |
(d) |
(e) |